Chief Innovation Officer, GE Healthcare
Terri Bresenham is GE Healthcare’s Chief Innovation Officer, leading the development of innovation and incubation of new growth models for the company. In this role she is responsible for identifying disruptive business models, unique healthcare partnerships, and new concepts in digital health, as well as additive manufacturing and diagnostic technologies that create better outcomes and value for care delivery systems in precision health, affordability and universal access.
Terri is passionate about healthcare and global health issues and has devoted more than 25 years to the field. Prior to this role, she led GE Healthcare’s Sustainable Healthcare Solutions business, including leadership of the company’s operations across the 70 countries of Africa, India and Southeast Asia. Her focus has always been on addressing the unmet customer and patient needs and has partnered with governments, clinicians and NGOs to support their complete healthcare system development. In addition, Terri led the development of a new portfolio of affordable healthcare technologies that is helping to bring access to quality care for the world’s most underserved populations.
She started her career as a clinical chemist, joined GE as an “Edison Engineer” and progressed through engineering and product management roles in Magnetic Resonance Imaging, Computed Tomography and Positron Emission Tomography. She then led several of GE Healthcare’s global product businesses: Bone Densitometry, Radiology, Women’s Health Ultrasound and Molecular Imaging businesses.
Terri earned her master’s degree in Biomedical Engineering from the University of Texas, and her bachelor’s in Medical Technology from the University of Tennessee. She is a board member of a number of healthcare organizations, is active in community-based health projects and is a champion for women leadership and development in global health.